Uncover key drivers, emerging technologies, and competitive movements shaping the insulated shippers market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Automated And Closed Cell Therapy Processing Systems Market size between 2026 and 2035?
The automated and closed cell therapy processing systems market size has seen rapid expansion in recent years. It is anticipated to increase from $1.53 billion in 2025 to $1.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. The historical growth of this market can be linked to manual cell processing methods, high contamination risks, limited workflow automation, reliance on traditional bioreactors, and the slow adoption of regenerative therapies.
The automated and closed cell therapy processing systems market is projected to experience swift expansion in the coming years. This market is predicted to reach $3.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.7%. Several factors contribute to this projected growth, including the emergence of integrated closed-system platforms, progress in robotics and microfluidics, the expansion of cell and gene therapy pipelines, more stringent regulatory compliance standards, and an increase in contract manufacturing organizations (cramos) for cell therapies. Key trends anticipated during the forecast period involve a greater embrace of single-use and closed systems, heightened demand for automated cell therapy workflows, an emphasis on reducing contamination and improving safety, the integration of multi-step cell processing platforms, and the broadening of regenerative medicine and oncology applications.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27214&type=smp
Which Drivers Are Impacting Market Performance In The Automated And Closed Cell Therapy Processing Systems Market?
The increasing need for personalized medicine is anticipated to fuel the expansion of the automated and closed-cell therapy processing systems market in the coming years. Personalized medicine involves medical interventions specifically designed based on an individual’s genetic, molecular, or cellular makeup, aiming to enhance effectiveness and reduce adverse reactions. This rising demand for personalized medicine stems from reinforced regulatory structures and encouraging incentives that favor the approval of specific and curative treatments over general-use pharmaceuticals. Automated and closed-cell therapy processing systems play a crucial role in personalized medicine by empowering manufacturers to deliver uniform, superior-quality, patient-tailored cell therapies that adhere to stringent regulatory requirements. For example, in May 2025, the Personalized Medicine Coalition (PMC), a US-based non-profit body, reported that the FDA sanctioned 18 new personalized medicines in 2024, among which six were gene- or cell-based therapies, constituting approximately 38 percent of all novel molecular entities. Consequently, the escalating demand for personalized medicine is a significant driver behind the growth of the automated and closed-cell therapy processing systems market.
Which Segments Are Contributing To The Growth Of The Automated And Closed Cell Therapy Processing Systems Market?
The automated and closed cell therapy processing systems market covered in this report is segmented –
1) By Component: Software, Hardware, Consumables
2) By Technology: Microfluidics, Robotics, Bioreactors, Single-Use Technology, Three-Dimensional (3D) Cell Culture
3) By Workflow: Cryopreservation, Separation, Fill-Finish, Expansion, Apheresis, Other Workflows
4) By Application: Oncology, Regenerative Medicine, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals
Subsegments:
1) By Software: Process Control Software, Data Management Software, Quality Monitoring Software, Workflow Automation Software, Integration Software
2) By Hardware: Cell Separation Devices, Bioreactors, Fluid Handling Systems, Centrifuges, Tubing And Connectors
3) By Consumables: Sterile Bags, Culture Media, Reagents And Buffers, Filters And Cartridges, Single-Use Tubing Sets
Which Trends Are Shaping Activity Within The Automated And Closed Cell Therapy Processing Systems Market?
Key players within the automated and closed cell therapy processing systems market are concentrating on developing advanced solutions, such as cell preparation platforms, to decrease manual labor and the risk of contamination during cell processing. Cell preparation platforms are automated systems utilized to efficiently isolate, process, and prepare cells for subsequent analysis or clinical use. For instance, in October 2024, Sino-Biocan Biotechnology Ltd., a China-based biotech company, unveiled the WUKONG Automated, Closed, Integrated Cell Processing System. This product launch represents a significant advance in cell therapy manufacturing, providing a fully automated, closed platform that streamlines procedures from blood collection to cell culture and final filling. It is engineered to support hospitals, pharmaceutical research and development teams, and contract development and manufacturing organizations by enhancing efficiency, reducing contamination risks, and ensuring good manufacturing practice-grade consistency through intelligent controls and real-time monitoring.
Who Are The Prominent Global Companies Shaping The Automated And Closed Cell Therapy Processing Systems Market Landscape?
Major companies operating in the automated and closed cell therapy processing systems market are Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., Autolus Therapeutics Plc.
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Automated And Closed Cell Therapy Processing Systems Market?
North America was the largest region in the automated and closed cell therapy processing systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated and closed cell therapy processing systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Automated And Closed Cell Therapy Processing Systems Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27214&type=smp
Browse Through More Reports Similar to the Global Automated And Closed Cell Therapy Processing Systems Market 2026, By The Business Research Company
People Counting System Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/people-counting-system-global-market-report
Sorting Machines Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/sorting-machines-global-market-report
Slot Machines Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/slot-machines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company